An observational study in Hernia, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2013-11-28.
Sponsored by Rigshospitalet, Denmark · Observational
Complex ventral hernia repair is a significant surgical challenge with high frequencies of both wound complications and recurrence. The Ventral Hernia Working Group (VHWG) described in 2010 recommendations regarding grading and technique of repair, which we have followed since November 2011.The purpose of the this study was to evaluate our results after biologic mesh repair of complex hernias.
Obervational study
Primare outcome: Surgical site occurence
Secondary outcome: Hernia recurrence
Biolocal mesh: Ventral hernia repair in a population with severe co-morbidity and contaminated hernia.
1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.
This study's enrollment of 16 is below the median of 120 across 327 observational studies indexed under Hernia.
Browse Hernia studies →Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
16 consecutive patients with biological mesh repair
Inclusion Criteria: Abdominal wall reconstruction with biological mesh -
Exclusion Criteria: Pregancy,
-
surgical site occurence
Wound infections, redness, seromas, dehiesience at the hernia implant site
Time frame: 30 days
hernia recurrence
Hernia recurrence at the hernia implant site
Time frame: 20 months
This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark